Hypertension Trial, Recruiting NCT07408154 Sponsor: Medical University of South Carolina Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07408154
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with open-angle glaucoma (including types related to exfoliation or pigment) or high eye pressure without glaucoma (called ocular hypertension)
  • People whose eye drainage angle is fully open when examined by a specialist (confirmed using a special lens called a gonioscope)
  • People who are able to give informed consent and attend follow-up appointments as required

Who may not be able to join:

  • People who have a type of glaucoma where the drainage angle is closed or blocked, or certain other specific types of glaucoma
  • People whose eye pressure remains above 35 mmHg even while receiving treatment
  • People who have a condition affecting the clear front surface of the eye (the cornea) that would interfere with the laser procedure or accurate eye pressure measurements
  • People who have had eye surgery within the past 6 months
  • People who have a medical reason why they cannot receive the medications or procedures used in this trial
  • People who have a cognitive impairment that prevents them from giving informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 April 2026
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Intraocular Pressure at 12 months from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov